Market Scenario
The global apheresis
market size is
projected to grow at a 8.90 % CAGR during the forecast period (2023-2030). The
apheresis market is witnessing significant growth globally, driven by
advancements in technology, increasing prevalence of chronic diseases, and
rising demand for blood components and plasma-derived therapies. Apheresis, a
medical procedure involving the separation and extraction of blood components
such as plasma, platelets, or white blood cells, plays a crucial role in
treating various conditions including autoimmune disorders, neurological
diseases, and hematologic malignancies. The market is characterized by a
growing number of applications, including therapeutic apheresis for treating
diseases like leukemia and myasthenia gravis, as well as the collection of
blood components for transfusion and research purposes.
Technological
innovations and the introduction of automated apheresis systems are driving
market expansion, offering improved efficiency, reduced procedure times, and
enhanced safety for patients. Moreover, the increasing demand for personalized
medicine and targeted therapies is expected to fuel further market growth as
apheresis procedures enable the precise extraction and manipulation of specific
blood components tailored to individual patient needs. With a rising emphasis
on blood safety and the growing adoption of apheresis procedures in both
developed and developing regions, the global apheresis market is projected to
continue its upward trajectory in the coming years, presenting lucrative
opportunities for market players and healthcare providers alike.
The
Apheresis market is witnessing significant growth, driven by the increasing
adoption of advanced therapeutic procedures such as selective plasma filtration
and plasma pheresis. Selective
plasma filtration is
a cutting-edge technique that allows for the precise removal of targeted
substances from the blood, offering a tailored approach to treating various
medical conditions. This process involves separating plasma from blood cells,
passing it through a specialized filter to remove specific components, and then
returning the purified plasma back to the patient's circulation. By selectively
removing harmful substances while preserving essential blood components,
selective plasma filtration has emerged as a promising tool in the treatment of
autoimmune disorders, neurological diseases, and certain cancers.
Competitive
Dashboard
The Major Apheresis
Players operating
the global market are Kaneka Corporation (Japan), Terumo BCT Inc. (US),
Fresenius Medical Care (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Medical
Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan),
HemaCare Corporation (US), Cerus Corporation (US), Haemonetics Corporation
(US), Kawasumi Laboratories Inc. (Japan), Therakos, Inc. (U.S.), and others.
Drivers
and Constraints Impacting the Market
With the
growing prevalence of chronic renal diseases and blood-related diseases, the
global apheresis
market is considered to stimulate
during the estimated period. Increasing complex surgical procedures, rising
demand for different component of blood, and growing number of accidents across
the globe are considered to augment the market growth in the coming years.
Demand for platelets and plasma has also increased which is further impacting
the global market positively. Moreover, with continuous advancement in
technology and growing need for advanced and automated devices, the market is
likely to foster.
On the
flip side, high cost of procedures and lack of skilled professionals are some
of the major factors considered to impede the market growth in the coming years.
Global
Apheresis Market: Segmental Analysis
The global
apheresis market has been segmented on the basis of product, procedure,
methods, application, end-users, and region.
By mode of
product, global apheresis market has been segmented into devices and
disposables. The devices segment has been further sub-segmented into platelets
separators, plasma separators, and others.
By mode of
procedure, the global apheresis market has been segmented into leukapheresis,
plateletpheresis, plasmapheresis, erythrocytapheresis, and others.
By mode of
methods, the global apheresis market has been segmented into filtration and
centrifugation. Among these, centrifugation is further sub-segmented into
intermittent flow centrifugation, continuous flow centrifugation, and others.
By mode of
application, the global apheresis market has been segmented into oncological
diseases, immunological diseases, hematological diseases, cardiovascular
diseases, renal diseases, neurological diseases, and others.
By mode of
end-users, the global apheresis market has been segmented into hospitals, blood
banks, and others.
Regional
Insights
Geographically,
apheresis market span across regions namely, America, Europe, Asia Pacific, and
Rest-of-the-World (RoW).
Among all
the regions, America is considered to hold the largest position in the global
market and is expected to maintain its dominance during the assessment period.
The growth is attributed to the advancement in technology and growing
opportunity for apheresis products coupled with the presence of a huge patient
population suffering from chronic diseases.
Asia
Pacific is considered to be the fastest growing region in the global market
owing to the growing demand for blood components for patients. Moreover, rapid
development in the healthcare industry along with growing expenditure on health
care is considered to contribute to the growth of the global market.
Related
Reports-
Chemiluminescence
Immunoassay Analyzers Market
FFP2
Grade Protective Masks Market
For more
information, Please Visit us @Market Research Future
Report
